BR112018068369A2 - composições e uso das mesmas - Google Patents

composições e uso das mesmas

Info

Publication number
BR112018068369A2
BR112018068369A2 BR112018068369A BR112018068369A BR112018068369A2 BR 112018068369 A2 BR112018068369 A2 BR 112018068369A2 BR 112018068369 A BR112018068369 A BR 112018068369A BR 112018068369 A BR112018068369 A BR 112018068369A BR 112018068369 A2 BR112018068369 A2 BR 112018068369A2
Authority
BR
Brazil
Prior art keywords
potential
composition
female individual
cognitive
compositions
Prior art date
Application number
BR112018068369A
Other languages
English (en)
Inventor
Silva Zolezzi Irma
HAUSER Jonas
Schneider Nora
DEONI Sean
Bartfai Tamas
Mary Samuel Tinu
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Priority claimed from PCT/EP2017/057575 external-priority patent/WO2017167898A2/en
Publication of BR112018068369A2 publication Critical patent/BR112018068369A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Abstract

a presente invenção refere-se a uma composição que compreende ao menos uma vitamina, para uso na promoção, suporte ou otimização de um ou mais dos seguintes: (i) remielinização; (ii) estrutura cerebral; (iii) conectividade cerebral; (iv) potencial intelectual; (v) potencial cognitivo; (vi) potencial de aprendizagem; e (vii) funcionamento cognitivo em uma prole de um indivíduo do sexo feminino, sendo que a dita composição é para administração ao indivíduo do sexo feminino.
BR112018068369A 2016-03-30 2017-03-30 composições e uso das mesmas BR112018068369A2 (pt)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US201662315152P 2016-03-30 2016-03-30
US201662315142P 2016-03-30 2016-03-30
US201662315134P 2016-03-30 2016-03-30
US201662315158P 2016-03-30 2016-03-30
US201662315163P 2016-03-30 2016-03-30
US201662328119P 2016-04-27 2016-04-27
PCT/EP2016/080796 WO2017167420A1 (en) 2016-03-30 2016-12-13 Compositions comprising vitamins and their use
PCT/EP2017/057575 WO2017167898A2 (en) 2016-03-30 2017-03-30 Compositions and their use

Publications (1)

Publication Number Publication Date
BR112018068369A2 true BR112018068369A2 (pt) 2019-01-15

Family

ID=57614348

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112018011404A BR112018011404A2 (pt) 2016-03-30 2016-12-13 composições que compreendem vitaminas e seu uso
BR112018068369A BR112018068369A2 (pt) 2016-03-30 2017-03-30 composições e uso das mesmas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR112018011404A BR112018011404A2 (pt) 2016-03-30 2016-12-13 composições que compreendem vitaminas e seu uso

Country Status (8)

Country Link
EP (2) EP3984533A3 (pt)
CN (2) CN108367009A (pt)
BR (2) BR112018011404A2 (pt)
CA (2) CA3004046A1 (pt)
MX (3) MX2018008519A (pt)
PH (1) PH12018501830A1 (pt)
SG (2) SG11201803025VA (pt)
WO (1) WO2017167420A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110157711B (zh) * 2019-02-01 2023-10-24 大连大学 一种人的srebp1基因编码区全长分段克隆的方法
WO2024038010A1 (en) 2022-08-18 2024-02-22 Société des Produits Nestlé S.A. Kit to promote developmental myelination

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0322589B1 (fr) 1987-12-23 1993-01-20 Societe Des Produits Nestle S.A. Procédé de préparation d'un hydrolysat de protéines de lactosérum et d'un aliment hypoallergéniques
EP0880902A1 (fr) 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
WO1999063943A2 (en) * 1998-06-12 1999-12-16 Craig Anthony Cooney Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring
WO2001011990A1 (en) 1999-04-29 2001-02-22 Societe Des Produits Nestle S.A. Composition for an infant formula having a low threonine content
WO2006099233A2 (en) * 2005-03-10 2006-09-21 Sciele Pharma, Inc. Compositions and methods for the treatment of osteoporosis and inflammatory joint disease
EP2454948A1 (en) 2010-11-23 2012-05-23 Nestec S.A. Oligosaccharide mixture and food product comprising this mixture, especially infant formula

Also Published As

Publication number Publication date
WO2017167420A1 (en) 2017-10-05
MX2018008519A (es) 2018-08-16
CN108778279A (zh) 2018-11-09
MX2018011334A (es) 2019-01-31
SG11201803025VA (en) 2018-05-30
EP3984533A2 (en) 2022-04-20
CN108367009A (zh) 2018-08-03
EP3984533A3 (en) 2022-09-07
EP3436015A2 (en) 2019-02-06
PH12018501830A1 (en) 2019-05-15
CA3004046A1 (en) 2017-10-05
CA3015434A1 (en) 2017-10-05
MX2022014682A (es) 2023-01-11
BR112018011404A2 (pt) 2018-12-04
SG11201806547SA (en) 2018-10-30

Similar Documents

Publication Publication Date Title
BR112018067999A2 (pt) composições compreendendo ácidos graxos e seu uso
BR112018010335A2 (pt) composição nutricional e fórmula para bebês para promover mielinização do cérebro
BR112018067423A2 (pt) composições que compreendem colina e uso das mesmas
CL2018001089A1 (es) Sales de valbenazina y polimorfos de las mismas.
CL2017001364A1 (es) Nuevos indazoles sustituidos, procedimientos para su preparación, preparaciones farmacéuticas que los contienen, así como su uso para la preparación de medicamentos.
BR112019004468A2 (pt) estimulantes de sgc
BR112016003229A8 (pt) composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
BR112015005743A2 (pt) derivados tricíclicos de quinoxalina e quinolina
CU20160087A7 (es) Indazolcarboxamidas, procedimientos para su preparación, preparaciones farmacéuticas que las contienen
BR112017024517A2 (pt) compostos de tetraidroquinolinona como moduladores ror gama
BR112017003346A2 (pt) derivados de pirazolopiridina, seus usos, e composição farmacêutica
UY36224A (es) Compuestos tricíclicos de imidazo-pirimidinona
BR112018011380A2 (pt) composições que compreendem fosfolipídeo e uso das mesmas
BR112015009989A2 (pt) estabilizante para a hialuronidase e formulação líquida que compreende hialuronidase
BR112016006388A2 (pt) inibidor seletivo da fosfatidilinositol 3-quinase gama
ES2721474T3 (es) Hidrodispersión cosmética estable
BR112018067730A2 (pt) composições que compreendem minerais e seu uso
BR112018068369A2 (pt) composições e uso das mesmas
CL2017000231A1 (es) Arilhidrazidas que contienen una fracción de 2-piridona como agentes antibacterianos selectivos
BR102015012091A8 (pt) método para a preparação de uma solução de albumina humana, e, composição
BR112016021471A8 (pt) derivados de ácido acético azaindol e seu uso como moduladores de receptor d2 de prosrtglandina
BR112016009214A8 (pt) uso de um composto para preparação de um medicamento para o tratamento de distrofia muscular e composição farmacêutica
BR112014029874A8 (pt) composição farmacêutica do tipo emulsão óleo em água, composições e uso da composição farmacêutica
WO2017167898A3 (en) Compositions comprising vitamins and their use
CL2014001833A1 (es) Uso de cascaras de palta con el fin de obtener un insaponificable de palta enriquecido en hidrocarburos alifaticos saturados y en esteroles, donde las cascaras representan del 5 al 50% en peso en relacion al peso total de las paltas utilizadas; metodo para obtener un insaponificable de palta; y dicho producto.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI N? 10196/2001, QUE MODIFICOU A LEI N? 9279/96, A CONCESS?O DA PATENTE EST? CONDICIONADA ? ANU?NCIA PR?VIA DA ANVISA. CONSIDERANDO A APROVA??O DOS TERMOS DO PARECER N? 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL N? 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVID?NCIAS CAB?VEIS.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.6.1 NA RPI NO 2631 DE 08/06/2021 POR TER SIDO INDEVIDA.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]